Key result
Anti-heart failure regimen led to remarkable improvement but incomplete recovery of heart failure features at 10 months post-partum in a 38-year-old woman with peripartum cardiomyopathy.
Case Report (n=1)
No
This case report highlights that peripartum cardiomyopathy can persist beyond 10 months post-partum despite medical therapy, emphasizing the need for prolonged follow-up.
Answers are grounded in this paper and cite their sources.
Supports extended surveillance in peripartum cardiomyopathy; leaves open recovery timelines with standard therapy.
Peripartum cardiomyopathy (PPCM) is a rare dilated cardiomyopathy that occurs in late pregnancy or in post-partum period. The features of PPCM usually resolve within six months post-partum following treatment. Factors associated with PPCM are not completely known. We document a rare case of PPCM with features that persisted beyond 10 months post-partum despite medical treatment, in a 38 year-old woman in Awka, Nigeria. The patient, 38 years old, presented in Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Nigeria, with features of heart failure in the 8 th month of pregnancy, without antecedent history of cardiac disease. Her parity was 5 including a set of twins in this index pregnancy. X-ray showed features of heart failure. Echocardiography revealed features of dilated cardiomyopathy. Diagnosis of PPCM was made. She was placed on anti-heart failure regimen. She has remarkable improvement but not complete recovery of heart failure features on three months of follow-up, and 10 months post-partum. This case report of PPCM occurring as the first case in five years in our center shows that PPCM is rare in southeast Nigeria. It further shows that heart failure in PPCM may not resolve completely 10 months post-partum, despite adequate treatment. There is a need for further search for etiology and associations.
No takes yet. Share an insight, caveat, or question.
Innocent Chukwuemeka Okoye (2016) conducted a case report in Peripartum cardiomyopathy (n=1). Anti-heart failure regimen was evaluated on Recovery of heart failure features. Anti-heart failure regimen led to remarkable improvement but incomplete recovery of heart failure features at 10 months post-partum in a 38-year-old woman with peripartum cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: